• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » German court hands down another mixed decision in TAVR spat between Boston Scientific, Edwards Lifesciences

German court hands down another mixed decision in TAVR spat between Boston Scientific, Edwards Lifesciences

March 9, 2017 By Brad Perriello

Edwards Lifesciences, Boston ScientificA German court issued a mixed decision in the international battle over transcatheter aortic valve replacement patents between Edwards Lifesciences (NYSE:EW) and Boston Scientific (NYSE:BSX), less than a week after a U.K. patent court handed down a similar TAVR decision.

Boston Scientific fired the 1st shot late last year in Germany with a lawsuit against Edwards, alleging that the next-generation Sapien 3 infringes claims covering the outer sealing skirt of Boston’s Lotus valve. Edwards claims that the Boston patent issued after Edwards launched the Sapien 3 valve in Europe and has leveled its own suits against its rival and subsidiary Sadra Medical; Boston Scientific filed counterclaims of its own in Germany and the U.K., where the Patents Court found 1 of its patents invalid but upheld another and ruled that Edwards infringes it.

Today the companies said that the German District Court of Düsseldorf found that the Edwards Sapien 3 TAVR infringes a pair of patents covering the outer seals of Boston’s Lotus valve. The Düsseldorf court also ruled that Boston Scientific did not infringe an Edwards patent, but did infringe a different TAVR patent (although Marlborough, Mass.-based Boston said it expects the European Patent Office to revoke that patent).

“We will continue to protect our intellectual property to ensure we can continue to bring forward innovative technologies that make a meaningful difference in the lives of patients,” Boston Scientific general counsel Tim Pratt said in prepared remarks. “We are pleased with the progress we are making with litigation in Europe, and believe the strength of our intellectual property will also be upheld in U.S. cases involving the same patents.”

For its part, Edwards pledged to appeal the ruling, as it did with the U.K. patent court decision, adding that it “believes that the company will ultimately prevail.”

Boston Scientific last month recalled all Lotus devices “due to reports of premature release of a pin connecting the Lotus Valve to the delivery system.”

Filed Under: Legal News, Patent Infringement, Replacement Heart Valves, Wall Street Beat Tagged With: Boston Scientific, Edwards Lifesciences

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy